A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia. Until now, the best-known medicines in this group – semaglutides, sold as Wegovy or Ozempic – and tirzepatides, sold as Mounjaro – have generally required weekly injections. The new daily tablet offers another option for people who would prefer not to or can't inject themselves. But how does it work? And will swallowing a pill make weight loss easier, cheaper or safer?
